PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Price to Book Value : 0.1569 for Sept. 4, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 0.1569 |
| September 03, 2026 | 0.1584 |
| September 02, 2026 | 0.155 |
| September 01, 2026 | 0.1574 |
| August 31, 2026 | 0.1615 |
| August 28, 2026 | 0.1661 |
| August 27, 2026 | 0.1742 |
| August 26, 2026 | 0.1743 |
| August 25, 2026 | 0.174 |
| August 24, 2026 | 0.1693 |
| August 21, 2026 | 0.1719 |
| August 20, 2026 | 0.1658 |
| August 19, 2026 | 0.1717 |
| August 18, 2026 | 0.169 |
| August 17, 2026 | 0.1748 |
| August 14, 2026 | 0.1777 |
| August 13, 2026 | 0.1773 |
| August 12, 2026 | 0.1765 |
| August 11, 2026 | 0.1773 |
| August 10, 2026 | 0.1761 |
| August 07, 2026 | 0.1903 |
| August 06, 2026 | 0.1903 |
| August 05, 2026 | 0.1902 |
| August 04, 2026 | 0.1938 |
| August 03, 2026 | 0.1857 |
| Date | Value |
|---|---|
| July 31, 2026 | 0.1857 |
| July 30, 2026 | 0.1935 |
| July 29, 2026 | 0.1888 |
| July 28, 2026 | 0.1902 |
| July 27, 2026 | 0.1886 |
| July 24, 2026 | 0.1935 |
| July 23, 2026 | 0.195 |
| July 22, 2026 | 0.1967 |
| July 21, 2026 | 0.1967 |
| July 20, 2026 | 0.201 |
| July 17, 2026 | 0.2041 |
| July 16, 2026 | 0.2127 |
| July 15, 2026 | 0.2274 |
| July 14, 2026 | 0.2222 |
| July 13, 2026 | 0.2128 |
| July 10, 2026 | 0.2246 |
| July 09, 2026 | 0.2257 |
| July 08, 2026 | 0.229 |
| July 07, 2026 | 0.2293 |
| July 06, 2026 | 0.2354 |
| July 02, 2026 | 0.2305 |
| July 01, 2026 | 0.2389 |
| June 30, 2026 | 0.2483 |
| June 29, 2026 | 0.2357 |
| June 26, 2026 | 0.2482 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.22 |
| Anika Therapeutics, Inc. | 2.029 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.760 |
Price to Book Value Related Metrics
| Price | 0.4865 |
| Earnings Yield | -635.3% |
| Market Cap | 5.223M |